Changes in mortality related to human immunodeficiency virus infection: Comparative analysis of inpatient deaths in 1995 and in 1999-2000

被引:78
作者
Jain, MK
Skiest, DJ
Cloud, JW
Jain, CL
Burns, D
Berggren, RE
机构
[1] Univ Texas, SW Med Ctr, Div Infect Dis, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX USA
[4] Tulane Univ, Hlth Sci Ctr, Infect Dis Sect, New Orleans, LA 70118 USA
关键词
D O I
10.1086/368186
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We conducted a retrospective chart review of human immunodeficiency virus (HIV)-infected patients who died in 1995 and in 1999-2000. We found an increase in the proportion of patients who died from an illness that was not related to acquired immunodeficiency syndrome (AIDS). Although there was a decrease in the prevalence of AIDS-defining illnesses, >85% of patients died with CD4 counts of <200 cells/μL. The leading cause of death was Pneumocystis carinii pneumonia (PCP). Nonadherence to therapy and new diagnosis of HIV infection were the leading reasons why patients were not receiving antiretroviral therapy. The leading causes of non-AIDS-related deaths in 1999-2000 were non-AIDS-defining infections and end-stage liver disease. At our hospital, PCP remains an important cause of death in the highly active antiretroviral therapy (HAART) era, possibly because >50% of HIV-infected patients who died were not receiving HAART. AIDS-defining illnesses continue to be a major cause of mortality in the HAART era in populations where access to care and adherence to HAART is limited.
引用
收藏
页码:1030 / 1038
页数:9
相关论文
共 24 条
  • [1] [Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
  • [2] Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
    Bica, I
    McGovern, B
    Dhar, R
    Stone, D
    McGowan, K
    Scheib, R
    Snydman, DR
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 492 - 497
  • [3] Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
    Brodt, HR
    Kamps, BS
    Gute, P
    Knupp, B
    Staszewski, S
    Helm, EB
    [J]. AIDS, 1997, 11 (14) : 1731 - 1738
  • [4] Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French departments of internal medicine/infectious diseases, in 1995 and 1997
    Cacoub, P
    Geffray, L
    Rosenthal, E
    Perronne, C
    Veyssier, P
    Raguin, G
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) : 1207 - 1214
  • [5] *CDCP, 2001, AIDS SURVEILL REP, V12, P28
  • [6] FREQUENCIES OF OPPORTUNISTIC DISEASES PRIOR TO DEATH AMONG HIV-INFECTED PERSONS
    CHAN, ISF
    NEATON, JD
    SARAVOLATZ, LD
    CRANE, LR
    OSTERBERGER, J
    [J]. AIDS, 1995, 9 (10) : 1145 - 1151
  • [7] Declining HIV/AIDS mortality in New York City
    Chiasson, MA
    Berenson, L
    Li, WH
    Schwartz, S
    Singh, T
    Forlenza, S
    Mojica, BA
    Hamburg, MA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (01): : 59 - 64
  • [8] Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
    Egger, M
    Hirschel, B
    Francioli, P
    Sudre, P
    Wirz, M
    Flepp, M
    Rickenbach, M
    Malinverni, R
    Vernazza, P
    Battegay, M
    Bernasconi, E
    Burgisser, P
    Erb, P
    Fierz, W
    Grob, P
    Gruninger, U
    Jeannerod, L
    Ledergerber, B
    Luthy, R
    Matter, L
    Opravil, M
    Paccaud, F
    Perrin, L
    Pichler, W
    Piffaretti, GC
    Rutschmann, O
    Zanetti, G
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117): : 1194 - 1199
  • [9] FOLCH EH, 2002, 9 C RETR OPP INF SEA, P327
  • [10] Autopsy findings in the acquired immunodeficiency syndrome (AIDS).: A report of 395 cases from the South of France
    Hofman, P
    Saint-Paul, MC
    Battaglione, V
    Michiels, JF
    Loubière, R
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1999, 195 (04) : 209 - 217